| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/15/1991 | US4985406 Central nervous system disorders, dopaminergic pathways |
| 01/15/1991 | US4985405 Therapeutic product based on organic silicon derivatives |
| 01/15/1991 | US4985404 Prolonged release of biologically active polypeptides |
| 01/15/1991 | US4985245 tPA-containing medical composition |
| 01/15/1991 | US4985243 Endonuclease |
| 01/15/1991 | US4985242 Polypeptide, Quaternary Ammonium Compound, Cellulose Ether |
| 01/15/1991 | US4985241 Therapeutic combination of free-radical scavenger and tumor necrosis factor |
| 01/15/1991 | CA2062975A1 Antagonists of gm-csf derived from the carboxyl terminus |
| 01/14/1991 | WO1991000909A1 Urate oxidase activity protein, recombinant gene coding therefor, expression vector, micro-organisms and transformed cells |
| 01/14/1991 | CA2036384A1 Modified transforming growth factor ó oligopeptides and pharmaceutical compositions thereof |
| 01/12/1991 | CA2020794A1 Galactanne extracted from klebsiella, process for its obtention and use as medicament |
| 01/12/1991 | CA2019893A1 Method of fractionating plasma protein |
| 01/11/1991 | WO1991000870A1 Somatotropin analogs |
| 01/11/1991 | CA2057035A1 Somatotropin analogs |
| 01/11/1991 | CA2020786A1 Treatment of obesity and essential hypertension and related disorders |
| 01/11/1991 | CA2020755A1 Solvent extraction process |
| 01/10/1991 | WO1991000360A1 Bispecific reagents for aids therapy |
| 01/10/1991 | WO1991000359A1 Particle-mediated transformation of animal somatic cells |
| 01/10/1991 | WO1991000354A1 Nucleic acid coding for the human testicular angiotensin conversion enzyme (eca) and its applications, in particular for the in vitro detection of said enzyme in the organism |
| 01/10/1991 | WO1991000352A1 Pestivirus nucleotide sequences and polypeptides |
| 01/10/1991 | WO1991000351A1 Fungal stress proteins |
| 01/10/1991 | WO1991000349A1 Cytokine synthesis inhibitory factor, antagonists thereof, and methods of using same |
| 01/10/1991 | WO1991000348A1 Modified vp1/p2a regions of the rhinoviral system |
| 01/10/1991 | WO1991000295A1 Novel antibodies reactive with human carcinomas |
| 01/10/1991 | WO1991000292A1 Compositions and methods for the synthesis of natriuretic protein receptor b and methods of use |
| 01/10/1991 | WO1991000291A1 Serpin variants |
| 01/10/1991 | WO1991000289A2 Targeted liposomes and methods for liposome-protein coupling |
| 01/10/1991 | WO1991000274A1 N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives |
| 01/10/1991 | WO1991000111A1 Targetting agents |
| 01/10/1991 | WO1991000103A1 Method for protecting bone marrow against chemotherapeutic drugs and radiation therapy using transforming growth factor beta 1 |
| 01/10/1991 | WO1991000101A1 Use of peroxidated lipids for the preparation of medication to be used in the treatment, by local application, of circulation deficiencies |
| 01/10/1991 | WO1991000100A2 Toxin uses |
| 01/10/1991 | WO1991000046A2 Method and apparatus for preparing fibrinogen adhesive from whole blood |
| 01/10/1991 | WO1990014427A3 Multivalent repressor of gene function |
| 01/10/1991 | WO1990014069A3 Keratinocyte autocrine factor |
| 01/10/1991 | WO1990013643A3 Glycoprotein hormone receptor molecules |
| 01/10/1991 | WO1990012874A3 Cysteine added variants of polypeptides and chemical modifications thereof |
| 01/10/1991 | DE3921644A1 New peptide(s) with immunological activity - used in treatment of acute or chronic infections, inflammatory processes and auto:immune diseases |
| 01/10/1991 | CA2062795A1 Bispecific reagents for aids therapy |
| 01/10/1991 | CA2059131A1 Compositions and methods for the synthesis of natriuretic protein receptor b and methods of use |
| 01/09/1991 | EP0407230A1 Sporozoite and liver-stage protein antigen of P. falciparum |
| 01/09/1991 | EP0407122A1 Novel modified PF4 compositions and methods of use |
| 01/09/1991 | EP0407092A1 Lymphocyte-activating factor, method for the preparation thereof and method for the proliferation of antibody-forming lymphocytes and production of antibody using the same |
| 01/09/1991 | EP0407017A1 Epoxysuccinic acid derivatives useful as specific inhibitors of cathepsin B |
| 01/09/1991 | EP0407008A2 Fibronectin fragment |
| 01/09/1991 | EP0406931A2 New analogues of all-bond retroinverted thymopentin, the method for the synthesis of the same and their employment for the preparation of pharmaceutical compositions |
| 01/09/1991 | EP0406913A1 Microbial expression of insulin-like growth factor |
| 01/09/1991 | EP0406856A2 Stabilized FGF composition and production thereof |
| 01/09/1991 | EP0406804A2 Modified biologically active protein |
| 01/09/1991 | EP0406745A1 Antibiotic GE 2270 factors A1, A2, A3 and H |
| 01/09/1991 | EP0406732A2 Highly concentrated and low-viscosity surfactant suspension |
| 01/09/1991 | EP0406725A1 Cyclic tetrapeptide and process for preparing the same |
| 01/09/1991 | EP0406557A2 Multivalent repressor of gene function |
| 01/09/1991 | EP0406545A2 Cloned gene encoding for bacteriocin from pediococcus acidilactici |
| 01/09/1991 | EP0406428A1 Peptide derivatives and their use |
| 01/09/1991 | EP0406416A1 Anti-hiv agent |
| 01/09/1991 | EP0406402A1 Cloning and expression of a variant gene of platelet factor 4 and compositions thereof to modulate immune responses |
| 01/09/1991 | EP0406369A1 Virus inactivated blood product and method |
| 01/09/1991 | EP0406367A1 Scavenger receptor protein and antibody thereto |
| 01/09/1991 | EP0406257A1 Proteins which induce immunological effector cell activation and chemattraction |
| 01/09/1991 | EP0197062B1 Anti-leishmania monoclonal antibodies, hybridomas secreting said antibodies, antigens of leishmania recognized by said antibodies, method for obtaining them and applications of said monoclonal antibodies and said antigens |
| 01/09/1991 | CN1048328A Srif-related peptides and uses thereof |
| 01/08/1991 | WO1991000739A1 Stable motilin preparation |
| 01/08/1991 | WO1991000738A1 Aqueous solution of motilin |
| 01/08/1991 | WO1991000725A2 Amino acid analog cck antagonists |
| 01/08/1991 | US4983598 Pharmaceutical composition containing diltiazem and angiotensin-converting enzyme inhibitor |
| 01/08/1991 | US4983581 Wound healing composition of IGF-I and TGF-β |
| 01/08/1991 | US4983402 Orally administerable ANF |
| 01/08/1991 | CA2535463A1 Octreotide-pamoate and its use in sustained release formulations of water soluble peptides |
| 01/08/1991 | CA2062755A1 Amino acid analog cck antagonists |
| 01/08/1991 | CA2035893A1 Stable preparation containing motilins |
| 01/08/1991 | CA2035892A1 Aqueous solution containing motilins |
| 01/08/1991 | CA2020654A1 Stabilized fgf composition and production thereof |
| 01/07/1991 | WO1991001004A1 Hybrid molecules |
| 01/07/1991 | WO1991000736A1 Dynorphin analogs specific for kappa opioid receptors |
| 01/07/1991 | CA2063712A1 Dynorphin analogs specific for kappa opioid receptors |
| 01/07/1991 | CA2035868A1 Hybrid molecules |
| 01/06/1991 | CA2020303A1 Cytokines |
| 01/06/1991 | CA2019086A1 Modified pf4 compositions and methods of use |
| 01/03/1991 | DE3920826A1 Prodn. of recombinant metallo-thionein proteins - and prodn. of apo-thionein proteins, and use as antiinflammatory agents |
| 01/03/1991 | DE3920282A1 DNA encoding TNF binding protein and TNF- receptor |
| 01/03/1991 | CA2009336A1 Cloned gene encoding for bacteriocin from pediococcus acidilactici |
| 01/02/1991 | EP0406216A2 Protein-S-containing pharmaceutical preparation |
| 01/02/1991 | EP0406175A2 Muramyl dipeptide derivatives |
| 01/02/1991 | EP0406122A1 Process for obtaining a native, wild-type human oestrogen receptor and its applications |
| 01/02/1991 | EP0406119A1 New peptide derivatives, process of their preparation and pharmaceutical compositions containing them |
| 01/02/1991 | EP0406087A2 Antihypertensives and food and drinks containing such antihypertensives |
| 01/02/1991 | EP0406029A1 Fungal stress proteins |
| 01/02/1991 | EP0405998A1 Antibiotic agents |
| 01/02/1991 | EP0405997A1 Antibiotic agent |
| 01/02/1991 | EP0405980A1 Cytokine synthesis inhibitory factor, antagonists thereof, and methods of using same |
| 01/02/1991 | EP0405905A2 Use of Isoxazolin-3-one Derivatives as antidepressants |
| 01/02/1991 | EP0405763A1 GRF peptides |
| 01/02/1991 | EP0405656A1 Hair growth composition |
| 01/02/1991 | EP0405537A1 N-substituted cycloalkyl and polycycloalkyl alpha-substituted Trp-Phe- and phenethylamine derivatives |
| 01/02/1991 | EP0405506A1 Tetrapeptide type-B CCK receptor ligands |
| 01/02/1991 | EP0405484A1 A physiologically active substance derived of malt and process for the production thereof |
| 01/02/1991 | EP0405467A2 A process for the determination of interleukins |
| 01/02/1991 | EP0405463A2 Supporting agents for anti-cancer therapy |
| 01/02/1991 | EP0405421A2 Anthraquinone derivatives and preparation thereof |